Learn how Oestra uses vaginal hormone delivery to support systemic hormone therapy with a simplified daily approach.

Here’s what researchers found.

Women in the UK are calling for a review of the Depo-Provera contraceptive injection after developing brain tumours they ...

Long-acting cabotegravir and rilpivirine (CAB/RPV) administered intramuscularly monthly or every 2 months yielded high rates of efficacy and a favorable safety profile in women with HIV, according to ...

Women who can’t take hormone therapy because of breast cancer or other diseases say they are deeply frustrated.

A new study suggests women with longer reproductive lifespans and those who take hormone therapy may have a higher risk of thyroid cancer. This effect was even stronger in women who used hormone ...

Higher awareness of the benefits of menopause hormone therapy (MHT) has led to rising demand for treatment – so much so that manufacturers can’t keep up and New Zealand’s drug-funding agency Pharmac ...

For decades, women have trusted Depo-Provera, a birth control injection manufactured by Pfizer, as a convenient and effective contraceptive option. However, recent research has uncovered alarming ...

Lenacapavir, a twice-yearly injectable antiretroviral, demonstrated 100% effectiveness for preventing HIV acquisition in a large study of young cisgender women in Africa, Gilead Sciences announced ...